Organon & Co.

Key metrics

Financial performance

Over the last 6 fiscal years Organon & Co.'s revenue declined from $7.78B to $6.22B, a compound annual decline rate of 3.7%. Net profit margin compressed from 41.4% to 3.0% over the same period - every figure below comes from the company's audited annual filings.

Dig into the full income statement, balance sheet, and cash flow statement with annual and quarterly views.

Key statistics

Latest filings

Browse the full filing history (435 filings)

Recent press releases

• Organon Reports Results for the First Quarter Ended March 31, 2026

  First quarter 2026 net income of $146 million and Adjusted EBITDA (non-GAAP) of $415 million, representing an Adjusted EBITDA margin of 28.4%.

• Organon Reports Results for the Fourth Quarter and Full Year ...

  Organon Reports Results for the Fourth Quarter and Full Year Ended December 31, 2025 · Full year 2025 revenue of $6.2 billion, down 3% on both an ...

• Organon Reports Results for the Second Quarter Ended June 30 ...

  Net income for the second quarter of 2025 was $145 million, or $0.56 per diluted share, compared with $195 million, or $0.75 per diluted share, ...

Similar companies

The largest companies sharing Organon & Co.'s SEC industry classification (pharmaceutical preparations).